# Technology Transfer: Resources

## Overview

This document provides citations, data sources, and further reading for the technology transfer analysis. Resources are organized by category to facilitate research and fact-checking.

## Primary Legal Sources

### Statutes

- **Bayh-Dole Act**: Patent and Trademark Law Amendments Act of 1980, P.L. 96-517, codified at 35 U.S.C. 200-212
- **Stevenson-Wydler Act**: Stevenson-Wydler Technology Innovation Act of 1980, P.L. 96-480, codified at 15 U.S.C. 3701-3714
- **Federal Technology Transfer Act of 1986**: P.L. 99-502, amending 15 U.S.C. 3710
- **National Competitiveness Technology Transfer Act of 1989**: P.L. 101-189, Title XXXI
- **Small Business Innovation Development Act of 1982**: P.L. 97-219, codified at 15 U.S.C. 638
- **Small Business Technology Transfer Act of 1992**: P.L. 102-564
- **National Technology Transfer and Advancement Act of 1995**: P.L. 104-113
- **Technology Transfer Commercialization Act of 2000**: P.L. 106-404
- **America Invents Act**: P.L. 112-29 (2011)
- **CHIPS and Science Act**: P.L. 117-167 (2022)
- **Inflation Reduction Act**: P.L. 117-169 (2022) (Medicare drug price negotiation provisions)
- **Government use authority**: 28 U.S.C. 1498

### Regulations

- **Bayh-Dole implementing regulations**: 37 C.F.R. Part 401
- **NIST Proposed March-In Framework (2023)**: 88 Fed. Reg. 85593 (December 8, 2023)
- **Executive Order 14036 on Promoting Competition**: 86 Fed. Reg. 36987 (July 14, 2021)

### Key Court Cases

- *Stanford v. Roche*, 563 U.S. 776 (2011) - Held that Bayh-Dole does not automatically vest title to federally funded inventions in the university; inventors must assign their rights
- *Madey v. Duke University*, 307 F.3d 1351 (Fed. Cir. 2002) - Narrowed the experimental use exception for university research
- *Zoltek Corp. v. United States*, 442 F.3d 1345 (Fed. Cir. 2006) - Addressed government use of patented inventions under 28 U.S.C. 1498

## Government Reports and Data

### Government Accountability Office (GAO)

- GAO. "Federal Research: Information on the Government's Right to Assert Ownership of Inventions." GAO-09-742. July 2009.
- GAO. "Technology Transfer: Clearer Priorities and Greater Use of Innovative Approaches Could Increase the Effectiveness of Technology Transfer at Department of Energy Laboratories." GAO-09-548. June 2009.
- GAO. "Technology Transfer: Federal Laboratory Consortium Should Increase Communication with Potential Customers to Improve Central Clearinghouse." GAO-15-127. October 2014.
- GAO. "Federal Research: Agencies Need to Enhance Policies to Address Foreign Influence." GAO-20-70. December 2019.

### Congressional Research Service (CRS)

- Schacht, Wendy H. "The Bayh-Dole Act: Selected Issues in Patent Policy and the Commercialization of Technology." CRS Report R44597. Updated regularly.
- Toole, Andrew A., and Callie Tutt. "An Overview of the SBIR and STTR Programs." CRS Report R43695.
- Sargent, John F., Jr. "Federal Research and Development (R&D) Funding: FY2024." CRS Report R47564.

### National Academies

- National Academies of Sciences, Engineering, and Medicine. *Government-University-Industry Research Roundtable: Proceedings.* Washington, DC: National Academies Press. Various years.
- National Research Council. *Managing University Intellectual Property in the Public Interest.* Washington, DC: National Academies Press, 2011.
- National Academies. *SBIR at the National Science Foundation.* Washington, DC: National Academies Press, 2016.
- National Academies. *SBIR and the Phase III Challenge of Commercialization.* Washington, DC: National Academies Press, 2007.

### NIST and Federal Laboratory Consortium

- National Institute of Standards and Technology. "Return on Investment Initiative for Unleashing American Innovation." Green paper, April 2019.
- Federal Laboratory Consortium for Technology Transfer. *FLC Annual Report on Technology Transfer.* Annual publication.

### AUTM Surveys

- Association of University Technology Managers. *AUTM Licensing Activity Survey.* Annual publication. Available at <https://autm.net/surveys-and-tools/surveys/licensing-survey>
- Association of University Technology Managers. *AUTM STATT Database.* Searchable technology transfer statistics. Available at <https://autm.net/surveys-and-tools/databases/statt>

### SBA SBIR/STTR Data

- Small Business Administration. *SBIR/STTR Annual Report.* Annual publication. Available at <https://www.sbir.gov/about>
- SBIR.gov award database. Available at <https://www.sbir.gov/awards>

## Academic Literature

### Bayh-Dole Act Analysis

- Mowery, David C., Richard R. Nelson, Bhaven N. Sampat, and Arvids A. Ziedonis. "The Growth of Patenting and Licensing by U.S. Universities: An Assessment of the Effects of the Bayh-Dole Act of 1980." *Research Policy* 30, no. 1 (2001): 99-119.
- Sampat, Bhaven N. "Patenting and US Academic Research in the 20th Century: The World Before and After Bayh-Dole." *Research Policy* 35, no. 6 (2006): 772-789.
- Grimaldi, Rosa, Martin Kenney, Donald S. Siegel, and Mike Wright. "30 Years After Bayh-Dole: Reassessing Academic Entrepreneurship." *Research Policy* 40, no. 8 (2011): 1045-1057.
- So, Anthony D., Bhaven N. Sampat, Arti K. Rai, et al. "Is Bayh-Dole Good for Developing Countries? Lessons from the US Experience." *PLoS Biology* 6, no. 10 (2008): e262.

### March-In Rights

- Arno, Peter S., and Michael H. Davis. "Why Don't We Enforce Existing Drug Price Controls? The Unrecognized and Unenforced Reasonable Pricing Requirements Imposed upon Patents Deriving in Whole or in Part from Federally Funded Research." *Tulane Law Review* 75 (2001): 631-693.
- Contreras, Jorge L. "The NIH March-In Rights Policy: Past, Present, and Future." *Yale Journal of Health Policy, Law, and Ethics* 20, no. 1 (2021): 1-56.
- Kapczynski, Amy, and Aaron S. Kesselheim. "Government Patent Use: A Legal Approach to Reducing Drug Spending." *Health Affairs* 35, no. 5 (2016): 791-797.

### Drug Pricing and Public Investment

- Cleary, Ekaterina Galkina, et al. "Contribution of NIH Funding to New Drug Approvals 2010-2016." *Proceedings of the National Academy of Sciences* 115, no. 10 (2018): 2329-2334.
- Nayak, Rahul K., Jerry Avorn, and Aaron S. Kesselheim. "Public Sector Financial Support for Late-Stage Discovery of New Drugs in the United States." *BMJ* 367 (2019): l5766.
- Ledley, Fred D., Shonali S. McCoy, Gregory Vaughan, and Ekaterina Galkina Cleary. "Profitability of Large Pharmaceutical Companies Compared with Other Large Public Companies." *JAMA* 323, no. 9 (2020): 834-843.
- Sarpatwari, Ameet, et al. "The US Government's Bayh-Dole March-In Rights: A Scoping Review and Implications for Access." *Health Affairs* 42, no. 5 (2023): 711-719.

### Technology Transfer Offices

- Siegel, Donald S., David Waldman, and Albert Link. "Assessing the Impact of Organizational Practices on the Relative Productivity of University Technology Transfer Offices." *Research Policy* 32, no. 1 (2003): 27-48.
- Feldman, Maryann, Irwin Feller, Janet Bercovitz, and Richard Burton. "Equity and the Technology Transfer Strategies of American Research Universities." *Management Science* 48, no. 1 (2002): 105-121.
- Thursby, Jerry G., and Marie C. Thursby. "Who Is Selling the Ivory Tower? Sources of Growth in University Licensing." *Management Science* 48, no. 1 (2002): 90-104.

### Federal Laboratory Technology Transfer

- Link, Albert N., Donald S. Siegel, and Barry Bozeman. "An Empirical Analysis of the Propensity of Academics to Engage in Informal University Technology Transfer." *Industrial and Corporate Change* 16, no. 4 (2007): 641-655.
- Bozeman, Barry. "Technology Transfer and Public Policy: A Review of Research and Theory." *Research Policy* 29, no. 4-5 (2000): 627-655.

### SBIR/STTR Programs

- Lerner, Josh. "The Government as Venture Capitalist: The Long-Run Impact of the SBIR Program." *Journal of Business* 72, no. 3 (1999): 285-318.
- Wallsten, Scott J. "The Effects of Government-Industry R&D Programs on Private R&D: The Case of the Small Business Innovation Research Program." *RAND Journal of Economics* 31, no. 1 (2000): 82-100.
- Audretsch, David B. "The SBIR Program: An Assessment of the Current State of the Art and Prospects for the Future." In *SBIR: The Two Decades of Program Innovation*, edited by David B. Audretsch. National Academies Press, 2020.

### Innovation Ecosystems

- Feldman, Maryann P., and Nichola Lowe. "Restructuring for Resilience." *Innovations: Technology, Governance, Globalization* 10, no. 1-2 (2015): 117-128.
- Lerner, Josh, and Josh Lerner. *Boulevard of Broken Dreams: Why Public Efforts to Boost Entrepreneurship and Venture Capital Have Failed -- and What to Do About It.* Princeton University Press, 2009.
- Mazzucato, Mariana. *The Entrepreneurial State: Debunking Public vs. Private Sector Myths.* London: Anthem Press, 2013.

## Policy Analysis and Advocacy

### Think Tanks and Policy Organizations

- Knowledge Ecology International (KEI). Reports and filings on march-in rights and drug pricing. Available at <https://www.keionline.org>
- Brookings Institution. Technology transfer and innovation policy papers. Available at <https://www.brookings.edu>
- Information Technology and Innovation Foundation (ITIF). Reports on technology policy and competitiveness. Available at <https://itif.org>
- Center for American Progress. Reports on drug pricing and public investment. Available at <https://www.americanprogress.org>
- American Enterprise Institute. Market-oriented analyses of innovation policy. Available at <https://www.aei.org>

### Data Sources

- AUTM Licensing Survey data: <https://autm.net/surveys-and-tools/surveys/licensing-survey>
- SBIR.gov awards database: <https://www.sbir.gov/awards>
- Federal Laboratory Consortium: <https://federallabs.org>
- NIH RePORTER (research funding database): <https://reporter.nih.gov>
- NSF NCSES data on university R&D: <https://ncses.nsf.gov>
- USPTO patent data: <https://www.uspto.gov/patents/data>

### Congressional Testimony and Hearings

- Senate Committee on Health, Education, Labor, and Pensions. Hearings on drug pricing and publicly funded research. Various dates.
- Senate Committee on Commerce, Science, and Transportation. Hearings on technology transfer and innovation. Various dates.
- House Committee on Science, Space, and Technology. Hearings on federal laboratory technology transfer. Various dates.
- House Committee on Energy and Commerce. Hearings on drug pricing. Various dates.

## Books

- Mowery, David C., Richard R. Nelson, Bhaven N. Sampat, and Arvids A. Ziedonis. *Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act.* Stanford University Press, 2004.
- Mazzucato, Mariana. *The Entrepreneurial State: Debunking Public vs. Private Sector Myths.* London: Anthem Press, 2013.
- Angell, Marcia. *The Truth About the Drug Companies: How They Deceive Us and What to Do About It.* Random House, 2005.
- Bok, Derek. *Universities in the Marketplace: The Commercialization of Higher Education.* Princeton University Press, 2003.
- Lerner, Josh. *Boulevard of Broken Dreams: Why Public Efforts to Boost Entrepreneurship and Venture Capital Have Failed -- and What to Do About It.* Princeton University Press, 2009.

---

## Document Navigation

- Previous: [Roadmap](08-roadmap.md)
- Up: [Science](../01-overview.md)
- Next: [Actions](10-actions.md)
